Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.

about

Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure

P2860

Q57072939-5A81EC80-EABF-4E15-BDD0-EF2198EAE5D4 Q58697190-3DF5AB23-1996-4434-8834-8F0ADE15D485

P2860

Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.

Item

http://www.wikidata.org/entity/Q48291376

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Blocking 17β-hydroxysteroid de ...... ndocrine therapeutic approach.

@en

Blocking 17β-hydroxysteroid de ...... ndocrine therapeutic approach.

@nl

type

Item

label

Blocking 17β-hydroxysteroid de ...... ndocrine therapeutic approach.

@en

Blocking 17β-hydroxysteroid de ...... ndocrine therapeutic approach.

@nl

prefLabel

Blocking 17β-hydroxysteroid de ...... ndocrine therapeutic approach.

@en

Blocking 17β-hydroxysteroid de ...... ndocrine therapeutic approach.

@nl

P1476

Blocking 17β-hydroxysteroid de ...... ndocrine therapeutic approach.

@en

P2093

Arjan J Groot

http://www.w3.org/2001/XMLSchema#string

Bert Delvoux

http://www.w3.org/2001/XMLSchema#string

ENITEC

http://www.w3.org/2001/XMLSchema#string

Gonda Fj Konings

http://www.w3.org/2001/XMLSchema#string

Helga B Salvesen

http://www.w3.org/2001/XMLSchema#string

Karlijn Mc Cornel

http://www.w3.org/2001/XMLSchema#string

Kim van Kuijk

http://www.w3.org/2001/XMLSchema#string

Loes Kooreman

http://www.w3.org/2001/XMLSchema#string

Marc Vooijs

http://www.w3.org/2001/XMLSchema#string

Marlies Y Bongers

http://www.w3.org/2001/XMLSchema#string

P2860

The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases

The Regulation of Steroid Action by Sulfation and Desulfation

In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production

Species used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1

Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Integrated view on 17beta-hydroxysteroid dehydrogenases.

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis.

Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels.

P304

203-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.5004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

244

http://www.w3.org/2001/XMLSchema#string

P50

Camilla Krakstad

Andrea Romano

Margaretha A. Skowron

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29144553

http://www.w3.org/2001/XMLSchema#string

Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.

about

P2860

P2860

Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698